G261V (p.Gly261Val) variant of GLA (Alpha-galactosidase A)

G261V (p.Gly261Val) in GLA (Alpha-galactosidase A) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic/likely pathogenic in the context of Cardiovascular phenotype; Fabry disease. The available variant effect predictions contribute to a CATVariant prioritization score of 0.84 / 1. The record also includes published literature and structural context.

G261V (p.Gly261Val) variant details